Fulcrum Therapeutics, Inc.

FULC

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001680581

SEC filings (opens in a new tab)

In the last 90 days, Fulcrum Therapeutics, Inc. insiders filed 2 open-market purchases and 0 sales; 154 institutions reported holding it in 13F filings for Q2 2026, worth $291.3M in total; no superinvestor holds it.

Q1 2024 vs. Q4 2023

How the institutions holding Fulcrum Therapeutics, Inc. changed between Q4 2023 and Q1 2024.

All holders in Q1 2024 All holders in Q4 2023

13F holders of FULC: Q4 2023 compared with Q1 2024
Measure	Q4 2023	Q1 2024	Change
Holders	101	126	+25
Shares	61.1M	60.4M	−705.2K (−1.2%)
Value	$412.3M	$569.7M	+$157.4M (+38.2%)

New holders (36)

Institutions that held Fulcrum Therapeutics, Inc. at the end of Q1 2024 but not at the end of Q4 2023.

Institutions new to FULC in Q1 2024
Institution	Shares	Value	% of portfolio
MPM Oncology Impact Management LP	1,137,108	$10.7M	1.73%
Silverarc Capital Management, LLC	398,436	$3.76M	1.05%
Caption Management, LLC	315,460	$2.98M	0.33%
Point72 Asset Management, L.P.	223,400	$2.11M	0.01%
Mass General Brigham, Inc	205,356	$1.94M	3.39%
Wellington Management Group LLP	172,660	$1.63M	0.00%
Cubist Systematic Strategies, LLC	171,507	$1.62M	0.02%
CIBC World Markets Corp	150,000	$1.42M	0.01%
HSBC Holdings PLC	149,627	$1.41M	0.00%
HRT Financial LP	123,408	$1.16M	0.01%
Point72 Asia (Singapore) Pte. Ltd.	89,547	$845.3K	0.22%
Brevan Howard Capital Management LP	88,483	$835.3K	0.08%
Gilder Gagnon Howe & Co LLC	65,600	$619.3K	0.01%
Squarepoint Ops LLC	54,560	$515.0K	0.00%
PDT Partners, LLC	49,518	$467.4K	0.04%
Trexquant Investment LP	47,222	$445.8K	0.01%
Marathon Trading Investment Management LLC	45,000	$424.8K	0.17%
Centiva Capital, LP	43,080	$406.7K	0.02%
Jump Financial, LLC	30,844	$291.2K	0.01%
Simplex Trading, LLC	30,739	$290.0K	0.01%
Polymer Capital Management (HK) LTD	18,874	$178.2K	0.04%
LMR Partners LLP	17,539	$165.6K	0.00%
Gsa Capital Partners LLP	15,162	$143.0K	0.01%
CTC Alternative Strategies, Ltd.	14,700	$138.8K	0.09%
XTX Topco Ltd	13,154	$124.2K	0.02%
Atom Investors LP	12,658	$119.5K	0.02%
Corton Capital Inc.	12,453	$117.6K	0.04%
SG Americas Securities, LLC	12,206	$115.0K	0.00%
Mirae Asset Global Investments Co., Ltd.	32,591	$111.1K	0.00%
Omers Administration Corp	10,600	$100.1K	0.00%
Fernwood Investment Management, LLC	7,613	$71.9K	0.02%
Catalyst Funds Management Pty Ltd	2,594	$24.5K	0.01%
BFSG, LLC	1,210	$11.4K	0.00%
Quadrant Capital Group LLC	1,038	$9.80K	0.00%
GAMMA Investing LLC	45	$425	0.00%
Macquarie Group Ltd	4,365	$41	0.00%

Sold out (11)

Institutions that held Fulcrum Therapeutics, Inc. at the end of Q4 2023 and filed for Q1 2024 without it.

Institutions that sold out of FULC in Q1 2024
Institution	Shares, Q4 2023	Value, Q4 2023
Logos Global Management LP	1,200,000	$8.10M
ClariVest Asset Management LLC	106,977	$722.1K
683 Capital Management, LLC	46,778	$315.8K
MYDA Advisors LLC	29,370	$198.2K
Sofinnova Investments, Inc.	28,600	$193.1K
Bank of New York Mellon Corp	19,831	$133.9K
Mirabella Financial Services LLP	16,914	$114.2K
LM Advisors LLC	16,132	$108.9K
Bank of Montreal	14,200	$97.8K
Boothbay Fund Management, LLC	11,730	$79.2K
Sherbrooke Park Advisers LLC	11,684	$78.9K